About 200 reports

China’s demand for Lung Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Lung Cancer
  • China
  • Labour Force
  • Industrial Production

The global lung cancer surgery market is projected to reach USD 6.7 billion by 2026 from USD 5.4 billion in 2020, at a CAGR of 3.8% during the forecast period. Market growth is largely driven by factors such as the technological advancements in lung cancer treatment, increasing incidence and prevalence of lung cancer, growing trend of smoking...

  • Lung Cancer
  • World
  • United States
  • North America
  • Europe
  • Asia
  • Cancer Incidence
  • Health Expenditure

Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update Summary This reports provides a data-driven overview of the current and future competitive landscape in Small Cell Lung Cancer therapeutics. Synopsis -...

  • Lung Cancer
  • World
  • Diagnostic Imaging Density
  • Prescription Drug Sales

Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., GlaxoSmithKlin, Vertiv Co., Sanofi-Aventis, Sun Pharmaceuticals Industries and Celgene Corporation. The global lung cancer drugs market is expected to grow from $28.45 billion in 2021 to $32.98...

  • Lung Cancer
  • World
  • Middle East
  • APAC
  • Biologics Penetration Rate
  • Mortality Rate

Global Lung Cancer Genomic Testing Market to Reach $3,279.8 Million by 2031 Global Lung Cancer Genomic Testing Market Industry Overview The lung cancer genomic testing medicine market was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of...

  • Lung Cancer
  • Genetic Testing
  • World

Small-Cell Lung Cancer (Oncology) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Drugs In Development, 2021, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape. Non-small cell lung...

  • Lung Cancer
  • World

Lung Cancer Surgery market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Lung Cancer Surgery Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Lung Cancer Surgery types, applications. Further, Lung Cancer...

  • Lung Cancer
  • World

Lung Cancer Therapeutics market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Lung Cancer Therapeutics Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Lung Cancer Therapeutics types, applications. Further,...

  • Lung Cancer
  • World

Abstract: What’s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...

  • Diagnostics
  • Lung Cancer
  • World
  • China
  • United States
  • Europe
  • Japan
  • APAC
  • Canada

Non-Small Cell Lung Cancer - Epidemiology Forecast to 2029 Summary Lung cancer is a disease of uncontrolled cell growth in the lung tissues.It is one of the most commonly occurring cancers in the world (International Agency for Research on Cancer, 2018). There are two main types of lung...

  • Lung Cancer
  • World
  • Smoking Prevalence
  • Cancer Incidence

Major players in the lung cancer drugs market are Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche Ltd, Novartis AG, and Pfizer Inc. The global lung cancer drugs market is expected to grow from $8.06 billion in 2020 to $8.67 billion in 2021 at a compound annual growth rate (CAGR) of 7.6%. The growth is mainly due to the...

  • Lung Cancer
  • World
  • Biologics Penetration Rate
  • Mortality Rate

Abstract: - Global Lung Cancer Therapeutics Market to Reach $44.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Lung Cancer Therapeutics estimated at US$20.4 Billion in the year 2020, is projected to reach a revised size of US$44.4 Billion by 2027, growing at aCAGR of 11.7% over the period 2020-2027....

  • Lung Cancer
  • World
  • China
  • United States

Global Lung Cancer Antibodies Market, Drug Sales & Clinical Trials Insight 2028 Report Highlights: • Lung Cancer Antibodies Market Global & Regional Outlook • Global Lung Cancer Antibodies Market Opportunity > USD 10 Billion • Global & Regional Sales Analysis On 11 Antibodies • Lung Cancer Immune Checkpoint...

  • Lung Cancer
  • World

Abstract: - Global Lung Cancer Surgery Market to Reach $37.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Lung Cancer Surgery estimated at US$25.5 Billion in the year 2020, is projected to reach a revised size of US$37.4 Billion by 2027, growing at aCAGR of 5.6% over the period 2020-2027. Thoracotomy,...

  • Lung Cancer
  • World
  • United States
  • China

Lung Cancer Surgery Market Report Overview Lung Cancer Surgery market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Lung Cancer Surgery market types and applications. It is a focused study on Lung Cancer Surgery market space including global...

  • Lung Cancer
  • World
  • Health Provider Density

Lung Cancer Therapeutics Market Report Overview Lung Cancer Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Lung Cancer Therapeutics market types and applications. It is a focused study on Lung Cancer Therapeutics market...

  • Lung Cancer
  • World
  • Health Provider Density

Small Cell Lung Cancer - Epidemiology Forecast to 2029 Summary SCLC accounts for 15% of all lung cancers.SCLC is an aggressive form of lung cancer where approximately 60-70% of patients already have distant metastasis at presentation. SCLC is predominant in elderly populations that are...

  • Lung Cancer
  • Epidemiology
  • Biomarker
  • World
  • Smoking Prevalence
  • Cancer Incidence

Global Non-small Cell Lung Cancer Drugs Market 2022-2026 The analyst has been monitoring the non-small cell lung cancer drugs market and it is poised to grow by $ 30.23 bn during 2022-2026, progressing at a CAGR of 17.1% during the forecast period. Our report on the non-small cell lung cancer drugs market provides a holistic...

  • Lung Cancer
  • World
  • Drug Approval

Abstract: - Global Interventional Oncology Devices Market to Reach $3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Interventional Oncology Devices estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3 Billion by 2027, growing at a CAGR of 5.7% over the analysis...

  • Liver Cancer
  • Lung Cancer
  • Breast Cancer
  • World
  • China
  • United States

Abstract: - Global Microwave Ablation Market to Reach $286.8 Million by 2027 - Amid the COVID-19 crisis, the global market for Microwave Ablation estimated at US$132.8 Million in the year 2020, is projected to reach a revised size of US$286.8 Million by 2027, growing at a CAGR of 11.6% over the analysis period 2020-2027....

  • Lung Cancer
  • Breast Cancer
  • Liver Cancer
  • World
  • China
  • United States

Lung Cancer Diagnostics Market Size, Share, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis Globally, lung cancer occurs when cells divide in the lungs uncontrollably—further causing tumours to grow, which reduces a person’s ability to breathe and spread to other...

  • Lung Cancer
  • World
  • APAC
  • Smoking Prevalence

Global Lung Cancer Therapeutics Market 2021-2025 The analyst has been monitoring the lung cancer therapeutics market and it is poised to grow by $ 6.79 bn during 2021-2025, progressing at a CAGR of 6.47% during the forecast period. Our report on the lung cancer therapeutics market provides a holistic analysis, market size...

  • Lung Cancer
  • World

Abstract: - Global Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market to Reach $44.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Non-Small Cell Lung Cancer (NSCLC) Therapeutics estimated at US$20 Billion in the year 2020, is projected to reach a revised size of US$44.6 Billion by 2027, growing...

  • Lung Cancer
  • Therapy
  • World
  • China
  • United States

Proto Oncogene Tyrosine Protein Kinase Src (Proto Oncogene c Src or pp60c src or SRC or EC 2.7.10.2) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary According to the recently published report ’Proto Oncogene Tyrosine Protein Kinase...

  • Cancer
  • Lung Cancer
  • Therapy
  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Taiwan
  • Cancer Mortality
  • Drug Approval

Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Lung Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Lung Cancer Diagnostic Tests pipeline products with comparative...

  • Lung Cancer

Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021 Summary Squamous Non-Small Cell Lung Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Squamous Non-Small Cell Lung Cancer pipeline landscape. The report provides comprehensive information...

  • Lung Cancer
  • World

The Global Immune Checkpoint Inhibitors Market size is expected to reach $75.9 billion by 2027, rising at a market growth of 16.1% CAGR during the forecast period. A checkpoint inhibitor is a kind of immunotherapy medicine that works by blocking proteins found on tumor cells that interfere with immune system activity. CTLA-4 (cytotoxic...

  • Cancer
  • Pharmaceutical
  • Cancer Immunotherapy
  • Lung Cancer
  • Drug Development
  • Clinical Trial
  • World
  • Drug Approval

The exosome research market is valued at an estimated USD 144 million in 2021 and is projected to reach USD 661 million by 2026, at a CAGR of 35.6% during the forecast period, owing to increased funding for life sciences research, the high global prevalence of cancer, and the increasing interest in exosome-based procedures. By...

  • Healthcare
  • In Vitro Diagnostics
  • Pharmaceutical
  • Hospital
  • Breast Cancer
  • Biotechnology
  • Infectious Disease
  • Prostate Cancer
  • Neurodegenerative Disease
  • Cardiovascular Disease
  • Lung Cancer
  • World
  • North America
  • Europe
  • APAC
  • Cancer Incidence
  • Disposable Income

Global Lung Cancer Liquid Biopsy Market 2020-2024 The analyst has been monitoring the lung cancer liquid biopsy market and it is poised to grow by $ 292.89 mn during 2020-2024, progressing at a CAGR of 16% during the forecast period. Our reports on the lung cancer liquid biopsy market provide a holistic analysis, market...

  • Lung Cancer
  • Genetic Testing
  • World

Small-Cell Lung Cancer - Pipeline Review, H1 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer - Pipeline Review, H1 2020, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape. Small cell lung cancer (SCLC)...

  • Lung Cancer
  • World